
Applied DNA Reports Fiscal Third Quarter 2019 Financial Results
August 13th, 2019
Applied DNA Reports Fiscal Third Quarter 2019 Financial Results
August 13th, 2019
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12th, 2019
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8th, 2019
APDN Signs Agreement with Schreiner Group to Protect Pharmaceutical Supply Chains
August 7th, 2019
Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET
August 6th, 2019
Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement
August 5th, 2019
Applied DNA Raises $1.5 Million In Secured Convertible Notes
July 17th, 2019
5-Year Agreement with Montblanc to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients
July 2nd, 2019
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1st, 2019